The Novartis case was a landmark judgment of the Supreme Court on the question of the evergreening of patents. This article examines the judgment and notes that the Supreme Court had taken a vital step in ensuring that life saving medication is freely and cheaply available to the public.
Read the full article co-authored with Achal Prabhala here.